Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

WPI

Watson (WPI)

Actavis, Inc.
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:WPI
DataHoraFonteTítuloCódigoCompanhia
29/01/201314:24ZacksMedTech Industry Stock Outlook - Jan 2013 - Industry OutlookNYSE:WPIActavis, Inc.
24/01/201312:00PR Newswire (US)Watson Pharmaceuticals, Inc. is Now Actavis, Inc.NYSE:WPIActavis, Inc.
23/01/201312:29PR Newswire (US)Watson Confirms Opana® ER Patent ChallengeNYSE:WPIActavis, Inc.
23/01/201310:30PR Newswire (US)Watson Acquires Uteron Pharma SANYSE:WPIActavis, Inc.
22/01/201314:30ZacksCanada Approves Forest's Bystolic - Analyst BlogNYSE:WPIActavis, Inc.
18/01/201311:00PR Newswire (US)Today's Research on Mylan and Watson Pharmaceuticals: One Drug Maker's Sorrow is Another One's JoyNYSE:WPIActavis, Inc.
14/01/201321:41Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NYSE:WPIActavis, Inc.
14/01/201321:41Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NYSE:WPIActavis, Inc.
11/01/201312:15PR Newswire (US)Watson To Host 2013 Investor Meeting January 25 In New YorkNYSE:WPIActavis, Inc.
09/01/201315:00ZacksForest Settles with Glenmark - Analyst BlogNYSE:WPIActavis, Inc.
08/01/201319:32Edgar (US Regulatory)Current report filing (8-K)NYSE:WPIActavis, Inc.
08/01/201319:32Edgar (US Regulatory)Current Report Filing (8-k)NYSE:WPIActavis, Inc.
08/01/201307:36ZacksStock Market News for January 8, 2013 - Market NewsNYSE:WPIActavis, Inc.
07/01/201312:52ZacksImpax Launches Opana ER Generic - Analyst BlogNYSE:WPIActavis, Inc.
07/01/201309:00ZacksWatson's Generic Product Approved - Analyst BlogNYSE:WPIActavis, Inc.
04/01/201316:21ZacksTough Times Ahead for Endo Health - Analyst BlogNYSE:WPIActavis, Inc.
04/01/201316:17ZacksPatent Challenge for Auxilium Pharma - Analyst BlogNYSE:WPIActavis, Inc.
03/01/201312:00PR Newswire (US)Watson's Generic Lysteda® Receives FDA ApprovalNYSE:WPIActavis, Inc.
02/01/201308:00ZacksWatson Files Velcade ANDA - Analyst BlogNYSE:WPIActavis, Inc.
28/12/201212:00PR Newswire (US)Watson Confirms Velcade® Patent ChallengeNYSE:WPIActavis, Inc.
28/12/201211:33PR Newswire (US)EmergingGrowth.com Special Report on RVPlus, Inc., Oil and Gas, and Patents infringement in PharmaceuticalsNYSE:WPIActavis, Inc.
26/12/201212:28MarketwiredLYB, WPI, SSYS and HW Freshly Hit a New 52-Week HighNYSE:WPIActavis, Inc.
21/12/201212:15PR Newswire (US)Watson to Present at the 31st Annual J.P. Morgan Healthcare ConferenceNYSE:WPIActavis, Inc.
20/12/201212:15PR Newswire (US)Watson to Present at 2013 Goldman Sachs Healthcare CEOs Unscripted: A View from the TopNYSE:WPIActavis, Inc.
14/12/201211:14ZacksAn End to Drug Patent Woes? - Analyst BlogNYSE:WPIActavis, Inc.
14/12/201206:20ZacksEndo Cuts EPS View, CEO to Retire - Analyst BlogNYSE:WPIActavis, Inc.
06/12/201211:34ZacksPharma & Biotech Stock Outlook - Dec 2012 - Industry OutlookNYSE:WPIActavis, Inc.
05/12/201222:00ZacksPharma & Biotech Stock Outlook - Dec 2012 - Zacks Analyst InterviewsNYSE:WPIActavis, Inc.
04/12/201209:20ZacksTeva's Guidance Lags Expectations - Analyst BlogNYSE:WPIActavis, Inc.
23/11/201206:50ZacksAnother Generic from Dr. Reddy's - Analyst BlogNYSE:WPIActavis, Inc.
 Apresentando as notícias mais relevantes sobre:NYSE:WPI